Amylyx Pharmaceuticals, Inc. — SCHEDULE 13G/A Filings
14 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Amylyx Pharmaceuticals, Inc. (AMLX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Amylyx Pharmaceuticals, Inc. has filed 14 SCHEDULE 13G/A documents with the SEC since 2015. To view all SEC filings by Amylyx Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POSASR
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000598 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-054741 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-000907 | Feb 12, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000374 | Feb 5, 2026 | — |
| SCHEDULE 13G/A | — | 0002012383-26-000638 | Jan 21, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-25-282838 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-005011 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004887 | Nov 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000102909-25-000074 | Oct 30, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003514 | Aug 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-002375 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-072740 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-021226 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-021288 | Feb 14, 2025 | — |